Medical Innovation Exchange

Adaptimmune to lay off up to 30% of staff as allogeneic ambitions stunted by cell line change

https://www.fiercebiotech.com/biotech/adaptimmune-lay-30-its-staff-allogeneic-ambitions-stunted-cell-line-change

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!